American Oncology Network Inc

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

American Oncology Network, Inc. engages in the provision of community-based oncology management. The company was founded in 2018 and is headquartered in Fort Myers, FL.

FORT MYERS, FL, Dec. 19, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (OTCQX: AONC), one of the fastest-growing oncology networks in the United States, proudly announces that its specialty pharmacy has achieved reaccreditation from the Accreditation Commission for Health Care (ACHC).

American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation

Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO join the Cape Coral physician team Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO join the Cape Coral physician team

Florida Oncology and Hematology and American Oncology Network Opens New Location in Cape Coral, Welcomes Medical Director, Dr. Van den Bergh, and Drs. Venkata Parsa, and Shivtaj Mann

FORT MYERS, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- American Oncology Network, Inc.  (AON) (OTCQX: AONC), a rapidly-growing network of community-based oncology practices, today announced it has qualified to trade on the OTCQX® Best Market. AON previously traded on NASDAQ.

American Oncology Network Announces the Commencement of OTCQX Trading

AON physicians and leaders present their latest cancer findings with fellow thought leaders at the annual conference. AON physicians and leaders present their latest cancer findings with fellow thought leaders at the annual conference.

American Oncology Network Announces the Research Studies Presented at the ASCO 2024 Annual Meeting

Veteran Financial Leader David Afshar will lead the company's financial and operating strategy. Veteran Financial Leader David Afshar will lead the company's financial and operating strategy.

American Oncology Network Appoints David Afshar as Chief Financial and Operating Officer

FORT MYERS, Fla., May 21, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Capital Market ("Nasdaq"). The Company's decision to delist its securities from Nasdaq was recommended to the Board of Directors (the "Board") of the Company by a Special Committee (the "Special Committee") of the Board comprised solely of independent directors.

American Oncology Network Announces Voluntary Delisting From Nasdaq

FORT MYERS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC), one of the nation's fastest-growing networks of community oncology practices, is pleased to announce the appointment of William “Bill” J.

American Oncology Network Appoints New Board Member

American Oncology Network, Inc. (NASDAQ:AONC ) Q1 2024 Earnings Conference Call May 16, 2024 8:30 AM ET Company Participants David Gould - Chief Financial Officer Todd Schonherz - Chief Executive Officer Conference Call Participants Operator Good morning and welcome to the American Oncology Network's First Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A.

American Oncology Network, Inc. (AONC) Q1 2024 Earnings Call Transcript

First Quarter 2024 Highlights Revenue of $364.3 million increased by 20.0% compared to the prior year quarter Patient encounter growth of 7.1% as compared to the prior year quarter Added 17 new providers to the AON platform Expanded in Texas and Maryland markets FORT MYERS, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- American Oncology Network, Inc. (NASDAQ: AONC), a leading oncology platform with an innovative model of physician-led, community-based oncology management, today announced financial results for the three-month period (“First Quarter 2024”) ended March 31, 2024.

American Oncology Network, Inc. Announces First Quarter 2024 Financial Results

FORT MYERS, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will change the release date of its first quarter 2024 financial results to Monday, May 20, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time the following day.

American Oncology Network Announces Date Change for First Quarter 2024 Earnings Release Date and Conference Call

FORT MYERS, Fla., May 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today that Dave Gould will step down as Chief Financial Officer, effective May 17, 2024, to pursue other opportunities. AON has appointed David Afshar, a seasoned public company executive, to fulfill the responsibilities of interim Chief Financial Officer, effective May 20, 2024. AON has initiated a process for a new Chief Financial Officer.

American Oncology Network Announces CFO Transition

The Foundation, a non-profit of the American Oncology Network, provides grants for essential non-medical expenses to cancer patients in need. The Foundation, a non-profit of the American Oncology Network, provides grants for essential non-medical expenses to cancer patients in need.

American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada

MACON, Ga., April 04, 2024 (GLOBE NEWSWIRE) -- Central Georgia Cancer Care is excited to announce their partnership with the American Oncology Network (AON) (Nasdaq: AONC), one of the nation's fastest-growing networks of community-based oncology practices, to further strengthen their patient care and services by utilizing the network's vast resources and expertise.

Central Georgia Cancer Care Joins American Oncology Network to Elevate Local Cancer Care Delivery

Hawaii Cancer Care partners with American Oncology Network to continue delivering quality cancer care to the community. Hawaii Cancer Care partners with American Oncology Network to continue delivering quality cancer care to the community.

American Oncology Network Expands to Hawaii, Welcomes New Practice to Network

TAMPA, Fla.--(BUSINESS WIRE)--Meaningful Insights Biotech Analytics (MiBA), an innovative healthcare technology company, is pleased to announce its official launch today and its commitment to transforming oncology, research and patient care. MiBA's debut marks the successful synergistic partnership between industry leaders American Oncology Network (AON) (Nasdaq: AONC) and Ascend Technologies Group (ATG). The company is led by a team of industry visionaries: Todd Schonherz, Mark Moch, Jason Bar.

MiBA: A New Era in Data-Driven Oncology Insights for a Healthier Tomorrow

American Oncology Network, Inc. (AONC) Q4 2023 Earnings Call Transcript

FORT MYERS, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- March 28, 2024 – American Oncology Network, Inc. (NASDAQ: AONC), a leading oncology platform with an innovative model of physician-led, community-based oncology management, today announced financial results for the three- and twelve-month periods ended December 31, 2023.

American Oncology Network, Inc. (“AON”) Announces Fourth Quarter and Full Year 2023 Financial Results

FORT MYERS, Fla., Feb. 26, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that company executives will participate at the Cowen Annual Health Care Conference in Boston on March 5, 2024. The AON management team will also be hosting a presentation at 2:10 PM Eastern Time and a live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.aoncology.com/. A replay of the webcast will be posted shortly after the presentation and will be available for a limited time following the event.

American Oncology Network to Present at Cowen Annual Health Care Conference

The community oncology practice is equipped to treat a wide variety of cancer types and is open to both new and current patients. The community oncology practice is equipped to treat a wide variety of cancer types and is open to both new and current patients.

Cancer and Blood Specialists of Georgia Opens New Oncology Clinic in Cumming

The network's physicians' research reports were selected after a thorough peer review process. The network's physicians' research reports were selected after a thorough peer review process.

Physicians from American Oncology Network Selected to Present at the American Society of Hematology Annual Meeting and Exposition

American Oncology is a healthcare stock with ample growth potential, but is still speculative due to uncertain valuation and thin margins. The company has experienced rapid growth over the past five years and is expected to continue on that trajectory. American Oncology uses a community-care business model and faces competition from larger firms, but the market for its services is large.

American Oncology: A Speculative Growth Prospect

Third Quarter 2023 Highlights Revenue of $336.3 million increased by 13.1% compared to the prior year quarter. Successfully transitioned to a publicly traded company with the completion of our business combination with Digital Transformation Opportunities Corp. Expanded into Florida market with Florida Oncology & Hematology Expanded into urology market with Triple Crown Urology in Arkansas Added 19 new providers to the AON platform FORT MYERS, Fla.

American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results

AON's specialty pharmacy reports success in reducing drug waste like unnecessary and early prescription refills. AON's specialty pharmacy reports success in reducing drug waste like unnecessary and early prescription refills.

American Oncology Network's Specialty Pharmacy Reports Zero Drug Waste After Value-Based Trial, Secures Unchanged Reimbursement Rate for 2024

American Oncology Cares Foundation and fund provide non-medical financial assistance to adult cancer patients. American Oncology Cares Foundation and fund provide non-medical financial assistance to adult cancer patients.

American Oncology Network Launches New Cancer Foundation

FORT MYERS, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, Inc. (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today that the Company will release its third quarter 2023 financial results on Tuesday, November 14, 2023, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day.

News for American Oncology Network Inc Stock (AONC)